116 related articles for article (PubMed ID: 11212150)
21. FR177995, a novel vacuolar ATPase inhibitor, exerts not only an inhibitory effect on bone destruction but also anti-immunoinflammatory effects in adjuvant-induced arthritic rats.
Niikura K; Nakajima S; Takano M; Yamazaki H
Bone; 2007 Apr; 40(4):888-94. PubMed ID: 17157574
[TBL] [Abstract][Full Text] [Related]
22. The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis.
Esser RE; Watts LM; Angelo RA; Thornburg LP; Prior JJ; Palmer JT
J Rheumatol; 1993 Jul; 20(7):1176-83. PubMed ID: 8371213
[TBL] [Abstract][Full Text] [Related]
23. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
Webster EL; Barrientos RM; Contoreggi C; Isaac MG; Ligier S; Gabry KE; Chrousos GP; McCarthy EF; Rice KC; Gold PW; Sternberg EM
J Rheumatol; 2002 Jun; 29(6):1252-61. PubMed ID: 12064844
[TBL] [Abstract][Full Text] [Related]
24. Effects of purified micronized flavonoid fraction (Detralex) on prophylactic treatment of adjuvant arthritis with methotrexate in rats.
Rovenský J; Svík K; Rovenská E; Stvrtinová V; Stancíková M
Isr Med Assoc J; 2008 May; 10(5):377-80. PubMed ID: 18605365
[TBL] [Abstract][Full Text] [Related]
25. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
Haruna Y; Morita Y; Yada T; Satoh M; Fox DA; Kashihara N
Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
[TBL] [Abstract][Full Text] [Related]
26. Antiinflammatory and chondroprotective effects of the aminobisphosphonate incadronate (YM175) in adjuvant induced arthritis.
Matsuo A; Shuto T; Hirata G; Satoh H; Matsumoto Y; Zhao H; Iwamoto Y
J Rheumatol; 2003 Jun; 30(6):1280-90. PubMed ID: 12784404
[TBL] [Abstract][Full Text] [Related]
27. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
28. Treatment of rat adjuvant arthritis with flavonoid (Detralex), methotrexate, and their combination.
Rovenský J; Stancíková M; Rovenská E; Stvrtina S; Stvrtinová V; Svík K
Ann N Y Acad Sci; 2009 Sep; 1173():798-804. PubMed ID: 19758231
[TBL] [Abstract][Full Text] [Related]
29. Effect of immunostimulatory ribomunyl on the preventive treatment of rat adjuvant arthritis with cyclosporine and methotrexate.
Rovensky J; Svík K; Stancíková M; Istok R
J Rheumatol; 2003 Sep; 30(9):2027-32. PubMed ID: 12966611
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis.
Bileviciute-Ljungar I; Saxne T; Spetea M
Rheumatology (Oxford); 2006 Mar; 45(3):295-302. PubMed ID: 16249243
[TBL] [Abstract][Full Text] [Related]
31. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis.
De Ceuninck F; Sabatini M; Renoux V; de Nanteuil G; Pastoureau P
J Rheumatol; 2003 Jul; 30(7):1561-4. PubMed ID: 12858459
[TBL] [Abstract][Full Text] [Related]
32. Anti-bone resorption activity of deer antler aqua-acupunture, the pilose antler of Cervus korean TEMMINCK var. mantchuricus Swinhoe (Nokyong) in adjuvant-induced arthritic rats.
Kim KH; Kim KS; Choi BJ; Chung KH; Chang YC; Lee SD; Park KK; Kim HM; Kim CH
J Ethnopharmacol; 2005 Jan; 96(3):497-506. PubMed ID: 15619570
[TBL] [Abstract][Full Text] [Related]
33. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Paola RD; Genovese T; Muià C; Caputi AP; Salvemini D
Arthritis Rheum; 2005 Jun; 52(6):1929-40. PubMed ID: 15934059
[TBL] [Abstract][Full Text] [Related]
34. [Inhibition of cartilage destruction in collagen-induced arthritis by altered CII 263-272 peptide: experiment with rats].
Yao ZQ; Zhao JX; Li R; Li ZG
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3055-8. PubMed ID: 17288836
[TBL] [Abstract][Full Text] [Related]
35. Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance.
Cuzzocrea S; Mazzon E; di Paola R; Genovese T; Muià C; Caputi AP; Salvemini D
Arthritis Rheum; 2005 Dec; 52(12):3755-60. PubMed ID: 16320326
[TBL] [Abstract][Full Text] [Related]
36. Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458.
Hannig G; Bernier SG; Hoyt JG; Doyle B; Clark E; Karp RM; Lorusso J; Westlin WF
Arthritis Rheum; 2007 Mar; 56(3):850-60. PubMed ID: 17328059
[TBL] [Abstract][Full Text] [Related]
37. Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment.
Bar-Yehuda S; Rath-Wolfson L; Del Valle L; Ochaion A; Cohen S; Patoka R; Zozulya G; Barer F; Atar E; Piña-Oviedo S; Perez-Liz G; Castel D; Fishman P
Arthritis Rheum; 2009 Oct; 60(10):3061-71. PubMed ID: 19790055
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
Magari K; Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
[TBL] [Abstract][Full Text] [Related]
39. Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.
Mirshafiey A; Cuzzocrea S; Rehm B; Mazzon E; Saadat F; Sotoude M
Scand J Immunol; 2005 May; 61(5):435-41. PubMed ID: 15882435
[TBL] [Abstract][Full Text] [Related]
40. The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation.
Futaki N; Harada M; Sugimoto M; Hashimoto Y; Honma Y; Arai I; Nakaike S; Hoshi K
J Pharm Pharmacol; 2009 May; 61(5):607-14. PubMed ID: 19405999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
